Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerlach

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Aktuelle Gerontologie|October 1, 1978
Tardive dyskinesia [proceedings]J Gerlach
The Journal of Clinical Psychiatry|January 7, 2000
The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatmentJ Gerlach
Wurzburger Medizinhistorische Mitteilungen|January 1, 1986
[Not Available]J Gerlach
Acta Neurologica Scandinavica|March 1, 1976
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trialJ Gerlach
Ugeskrift for Laeger|August 22, 1983
[Sulpiride (Dogmatil). A new antipsychosis agent (neuroleptic) with few side effects]J Gerlach
L'Encephale|September 1, 1988
Tardive dyskinesia. Pathophysiological mechanisms and clinical trialsJ Gerlach
Nordisk Medicin|January 1, 1987
[Profile of the adverse effects of neuroleptic drugs in relation to its receptor binding]J Gerlach
Psychopharmacology|March 16, 1977
Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonismJ Gerlach
International Clinical Psychopharmacology|January 1, 1995
Depot neuroleptics in relapse prevention: advantages and disadvantagesJ Gerlach
Munchener Medizinische Wochenschrift (1950)|January 9, 1970
[The definition of death in medicine. Logical and semantic principles]J Gerlach
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Aktuelle Gerontologie|October 1, 1978
Tardive dyskinesia [proceedings]J Gerlach
The Journal of Clinical Psychiatry|January 7, 2000
The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatmentJ Gerlach
Wurzburger Medizinhistorische Mitteilungen|January 1, 1986
[Not Available]J Gerlach
Acta Neurologica Scandinavica|March 1, 1976
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trialJ Gerlach
Ugeskrift for Laeger|August 22, 1983
[Sulpiride (Dogmatil). A new antipsychosis agent (neuroleptic) with few side effects]J Gerlach
L'Encephale|September 1, 1988
Tardive dyskinesia. Pathophysiological mechanisms and clinical trialsJ Gerlach
Nordisk Medicin|January 1, 1987
[Profile of the adverse effects of neuroleptic drugs in relation to its receptor binding]J Gerlach
Psychopharmacology|March 16, 1977
Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonismJ Gerlach
International Clinical Psychopharmacology|January 1, 1995
Depot neuroleptics in relapse prevention: advantages and disadvantagesJ Gerlach
Munchener Medizinische Wochenschrift (1950)|January 9, 1970
[The definition of death in medicine. Logical and semantic principles]J Gerlach
Pageof 28